Expanding the Promise of Immunotherapy

Leveraging elite immune responses to develop novel cancer immunotherapies


The Right People in the Right Place at the Right Time

Making advancements in immuno-oncology through strategic partnerships



March 9, 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round

October 10, 2016
OncoResponse Secures $7M in Supplemental Series A Funding